150 related articles for article (PubMed ID: 28697486)
1. Oxidant production and SOD1 protein expression in single skeletal myofibers from Down syndrome mice.
Cowley PM; Nair DR; DeRuisseau LR; Keslacy S; Atalay M; DeRuisseau KC
Redox Biol; 2017 Oct; 13():421-425. PubMed ID: 28697486
[TBL] [Abstract][Full Text] [Related]
2. Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition.
Cowley PM; Keslacy S; Middleton FA; DeRuisseau LR; Fernhall B; Kanaley JA; DeRuisseau KC
Am J Physiol Regul Integr Comp Physiol; 2012 Dec; 303(12):R1251-60. PubMed ID: 23115123
[TBL] [Abstract][Full Text] [Related]
3. Combined Microscopic and Metabolomic Approach to Characterize the Skeletal Muscle Fiber of the Ts65Dn Mouse, A Model of Down Syndrome.
Cisterna B; Sobolev AP; Costanzo M; Malatesta M; Zancanaro C
Microsc Microanal; 2020 Oct; 26(5):1014-1023. PubMed ID: 32867866
[TBL] [Abstract][Full Text] [Related]
4. Progressive impairment of CaV1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis.
Beqollari D; Romberg CF; Dobrowolny G; Martini M; Voss AA; Musarò A; Bannister RA
Skelet Muscle; 2016; 6():24. PubMed ID: 27340545
[TBL] [Abstract][Full Text] [Related]
5. Muscle stem cell dysfunction impairs muscle regeneration in a mouse model of Down syndrome.
Pawlikowski B; Betta ND; Elston T; Williams DA; Olwin BB
Sci Rep; 2018 Mar; 8(1):4309. PubMed ID: 29523805
[TBL] [Abstract][Full Text] [Related]
6. Early impacts of modified food consistency on oromotor outcomes in mouse models of Down syndrome.
Glass TJ; Twadell SL; Valmadrid LC; Connor NP
Physiol Behav; 2019 Feb; 199():273-281. PubMed ID: 30496741
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle weakness due to deficiency of CuZn-superoxide dismutase is associated with loss of functional innervation.
Larkin LM; Davis CS; Sims-Robinson C; Kostrominova TY; Van Remmen H; Richardson A; Feldman EL; Brooks SV
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1400-7. PubMed ID: 21900648
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and antioxidant enzyme upregulation in SOD1-G93A mouse skeletal muscle.
Mahoney DJ; Kaczor JJ; Bourgeois J; Yasuda N; Tarnopolsky MA
Muscle Nerve; 2006 Jun; 33(6):809-16. PubMed ID: 16583367
[TBL] [Abstract][Full Text] [Related]
9. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
10. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen.
Wood-Allum CA; Barber SC; Kirby J; Heath P; Holden H; Mead R; Higginbottom A; Allen S; Beaujeux T; Alexson SE; Ince PG; Shaw PJ
Brain; 2006 Jul; 129(Pt 7):1693-709. PubMed ID: 16702190
[TBL] [Abstract][Full Text] [Related]
11. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
[TBL] [Abstract][Full Text] [Related]
12. Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.
Keck-Wherley J; Grover D; Bhattacharyya S; Xu X; Holman D; Lombardini ED; Verma R; Biswas R; Galdzicki Z
Dev Neurosci; 2011; 33(5):451-67. PubMed ID: 22042248
[TBL] [Abstract][Full Text] [Related]
13. Sod1 gene ablation in adult mice leads to physiological changes at the neuromuscular junction similar to changes that occur in old wild-type mice.
Ivannikov MV; Van Remmen H
Free Radic Biol Med; 2015 Jul; 84():254-262. PubMed ID: 25841780
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome.
Gulesserian T; Seidl R; Hardmeier R; Cairns N; Lubec G
J Investig Med; 2001 Jan; 49(1):41-6. PubMed ID: 11217146
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
[TBL] [Abstract][Full Text] [Related]
16. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
[TBL] [Abstract][Full Text] [Related]
17. Down's syndrome astrocytes have greater antioxidant capacity than euploid astrocytes.
Sebastià J; Cristòfol R; Pertusa M; Vílchez D; Torán N; Barambio S; Rodríguez-Farré E; Sanfeliu C
Eur J Neurosci; 2004 Nov; 20(9):2355-66. PubMed ID: 15525277
[TBL] [Abstract][Full Text] [Related]
18. Defective hematopoietic stem cell and lymphoid progenitor development in the Ts65Dn mouse model of Down syndrome: potential role of oxidative stress.
Lorenzo LP; Chen H; Shatynski KE; Clark S; Yuan R; Harrison DE; Yarowsky PJ; Williams MS
Antioxid Redox Signal; 2011 Oct; 15(8):2083-94. PubMed ID: 21504363
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Skeletal Muscle Fibers of SOD1 Knockout Mice.
Nagahisa H; Okabe K; Iuchi Y; Fujii J; Miyata H
Oxid Med Cell Longev; 2016; 2016():9345970. PubMed ID: 26798428
[TBL] [Abstract][Full Text] [Related]
20. Biphasic role of nuclear factor-kappa B on cell survival and COX-2 expression in SOD1 Tg astrocytes after oxygen glucose deprivation.
Lee YS; Song YS; Giffard RG; Chan PH
J Cereb Blood Flow Metab; 2006 Aug; 26(8):1076-88. PubMed ID: 16395278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
